These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. Du M, Wang X, Yuan L, Liu B, Mao X, Huang D, Yang L, Huang K, Zhang F, Wang Y, Luo X, Wang C, Peng J, Liang M, Huang D, Huang K. J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288 [Abstract] [Full Text] [Related]
10. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Widjaja AA, Singh BK, Adami E, Viswanathan S, Dong J, D'Agostino GA, Ng B, Lim WW, Tan J, Paleja BS, Tripathi M, Lim SY, Shekeran SG, Chothani SP, Rabes A, Sombetzki M, Bruinstroop E, Min LP, Sinha RA, Albani S, Yen PM, Schafer S, Cook SA. Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624 [Abstract] [Full Text] [Related]
14. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction. Li S, Li X, Chen F, Liu M, Ning L, Yan Y, Zhang S, Huang S, Tu C. J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558 [Abstract] [Full Text] [Related]
19. Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis. Win S, Min RWM, Zhang J, Kanel G, Wanken B, Chen Y, Li M, Wang Y, Suzuki A, Aung FWM, Murray SF, Aghajan M, Than TA, Kaplowitz N. Hepatology; 2021 Dec; 74(6):3127-3145. PubMed ID: 34331779 [Abstract] [Full Text] [Related]